Skip to main content
Top
Published in: Trials 1/2012

Open Access 01-12-2012 | Study protocol

Reducing inappropriate, anticholinergic and psychotropic drugs among older residents in assisted living facilities: study protocol for a randomized controlled trial

Authors: Kaisu H Pitkala, Anna-Liisa Juola, Helena Soini, Marja-Liisa Laakkonen, Hannu Kautiainen, Mariko Teramura-Gronblad, Harriet Finne-Soveri, Mikko Bjorkman

Published in: Trials | Issue 1/2012

Login to get access

Abstract

Background

Use of inappropriate drugs is common among institutionalized older people. Rigorous trials investigating the effect of the education of staff in institutionalized settings on the harm related to older people’s drug treatment are still scarce. The aim of this trial is to investigate whether training professionals in assisted living facilities reduces the use of inappropriate drugs among residents and has an effect on residents’ quality of life and use of health services.

Methods and design

During years 2011 and 2012, a sample of residents in assisted living facilities in Helsinki (approximately 212) will be recruited, having offered to participate in a trial aiming to reduce their harmful drugs. Their wards will be randomized into two arms: one, those in which staff will be trained in two half-day sessions, including case studies to identify inappropriate, anticholinergic and psychotropic drugs among their residents, and two, a control group with usual care procedures and delayed training. The intervention wards will have an appointed nurse who will be responsible for taking care of the medication of the residents on her ward, and taking any problems to the consulting doctor, who will be responsible for the overall care of the patient. The trial will last for twelve months, the assessment time points will be zero, six and twelve months.
The primary outcomes will be the proportion of persons using inappropriate, anticholinergic, or more than two psychotropic drugs, and the change in the mean number of inappropriate, anticholinergic and psychotropic drugs among residents. Secondary endpoints will be, for example, the change in the mean number of drugs, the proportion of residents having significant drug-drug interactions, residents' health-related quality of life (HRQOL) according to the 15D instrument, cognition according to verbal fluency and clock-drawing tests and the use and cost of health services, especially hospitalizations.

Discussion

To our knowledge, this is the first large-scale randomized trial exploring whether relatively light intervention, that is, staff training, will have an effect on reducing harmful drugs and improving QOL among institutionalized older people.

Trial registration

ACTRN12611001078943
Appendix
Available only for authorised users
Literature
1.
go back to reference Hosia-Randell HM, Muurinen SM, Pitkälä KH: Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging. 2008, 25: 683-692. 10.2165/00002512-200825080-00005.CrossRefPubMed Hosia-Randell HM, Muurinen SM, Pitkälä KH: Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging. 2008, 25: 683-692. 10.2165/00002512-200825080-00005.CrossRefPubMed
2.
go back to reference Olsson J, Bergman A, Carlsten A, Oké T, Bernsten C, Schmidt IK, Fastbom J: Quality of drug prescribing in elderly people in nursing homes and special care units for dementia: a cross-sectional computerized pharmacy register analysis. Clin Drug Investig. 2010, 30: 289-300. 10.2165/11534320-000000000-00000.CrossRefPubMed Olsson J, Bergman A, Carlsten A, Oké T, Bernsten C, Schmidt IK, Fastbom J: Quality of drug prescribing in elderly people in nursing homes and special care units for dementia: a cross-sectional computerized pharmacy register analysis. Clin Drug Investig. 2010, 30: 289-300. 10.2165/11534320-000000000-00000.CrossRefPubMed
3.
go back to reference Onder G, Liperoti R, Fialova D, Topinkova E, Tosato M, Danese P, Gallo PF, Carpenter I, Finne-Soveri H, Gindin J, Bernabei R, Landi F: SHELTER project: polypharmacy in nursing home in Europe: results from the shelter study. J Gerontol A Biol Sci Med Sci. 2012, 67A: 698-704. 10.1093/gerona/glr233.CrossRef Onder G, Liperoti R, Fialova D, Topinkova E, Tosato M, Danese P, Gallo PF, Carpenter I, Finne-Soveri H, Gindin J, Bernabei R, Landi F: SHELTER project: polypharmacy in nursing home in Europe: results from the shelter study. J Gerontol A Biol Sci Med Sci. 2012, 67A: 698-704. 10.1093/gerona/glr233.CrossRef
4.
go back to reference Hosia-Randell H, Pitkälä K: Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Ageing. 2005, 22: 793-800. 10.2165/00002512-200522090-00008.CrossRef Hosia-Randell H, Pitkälä K: Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Ageing. 2005, 22: 793-800. 10.2165/00002512-200522090-00008.CrossRef
5.
go back to reference Field TS, Gurwitz JH, Avorn J, McCormick D, Jain S, Eckler M, Benser M, Bates DW: Risk factors for adverse drug events among nursing home residents. Arch Intern Med. 2001, 161: 1629-1634. 10.1001/archinte.161.13.1629.CrossRefPubMed Field TS, Gurwitz JH, Avorn J, McCormick D, Jain S, Eckler M, Benser M, Bates DW: Risk factors for adverse drug events among nursing home residents. Arch Intern Med. 2001, 161: 1629-1634. 10.1001/archinte.161.13.1629.CrossRefPubMed
6.
go back to reference Hanlon JT, Schmader KE, Ruby CM, Weinberger M: Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001, 49: 200-209. 10.1046/j.1532-5415.2001.49042.x.CrossRefPubMed Hanlon JT, Schmader KE, Ruby CM, Weinberger M: Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001, 49: 200-209. 10.1046/j.1532-5415.2001.49042.x.CrossRefPubMed
8.
go back to reference Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC: Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991, 151: 1825-832.PubMed Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC: Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991, 151: 1825-832.PubMed
9.
go back to reference Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH: Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003, 163: 2716-2724. 10.1001/archinte.163.22.2716.CrossRefPubMed Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH: Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003, 163: 2716-2724. 10.1001/archinte.163.22.2716.CrossRefPubMed
10.
go back to reference McLeod PJ, Huang AR, Tamblyn RM, Gayton DC: Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Can Med Assoc J. 1997, 156: 385-391. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC: Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Can Med Assoc J. 1997, 156: 385-391.
11.
go back to reference Gallagher P, O'Mahony D: STOPP (Screening tool of older persons' potentially inappropriate prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing. 2008, 37: 673-679. 10.1093/ageing/afn197.CrossRefPubMed Gallagher P, O'Mahony D: STOPP (Screening tool of older persons' potentially inappropriate prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing. 2008, 37: 673-679. 10.1093/ageing/afn197.CrossRefPubMed
12.
go back to reference Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT: Appropriate prescribing in elderly people: how well can it be measured and optimised?. Lancet. 2007, 370: 173-184. 10.1016/S0140-6736(07)61091-5.CrossRefPubMed Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT: Appropriate prescribing in elderly people: how well can it be measured and optimised?. Lancet. 2007, 370: 173-184. 10.1016/S0140-6736(07)61091-5.CrossRefPubMed
13.
go back to reference Raivio MM, Laurila JV, Strandberg TE, Tilvis RS, Pitkala KH: Use of inappropriate medications and their prognostic significance in hospital and nursing home patients with and without dementia in Finland. Drugs Aging. 2006, 23: 333-343. 10.2165/00002512-200623040-00006.CrossRefPubMed Raivio MM, Laurila JV, Strandberg TE, Tilvis RS, Pitkala KH: Use of inappropriate medications and their prognostic significance in hospital and nursing home patients with and without dementia in Finland. Drugs Aging. 2006, 23: 333-343. 10.2165/00002512-200623040-00006.CrossRefPubMed
14.
go back to reference Lau DT, Kasper JD, Potter DE, Lyles A: Potentially inappropriate medication prescriptions among elderly nursing home residents: their scope and associated resident and facility characteristics. Health Serv Res. 2004, 39: 1257-1276. 10.1111/j.1475-6773.2004.00289.x.CrossRefPubMedPubMedCentral Lau DT, Kasper JD, Potter DE, Lyles A: Potentially inappropriate medication prescriptions among elderly nursing home residents: their scope and associated resident and facility characteristics. Health Serv Res. 2004, 39: 1257-1276. 10.1111/j.1475-6773.2004.00289.x.CrossRefPubMedPubMedCentral
15.
go back to reference Stafford AC, Alswayan MS, Tenni PC: Inappropriate prescribing in older residents of Australian care homes. J Clin Pharm Ther. 2011, 36: 33-44. 10.1111/j.1365-2710.2009.01151.x.CrossRefPubMed Stafford AC, Alswayan MS, Tenni PC: Inappropriate prescribing in older residents of Australian care homes. J Clin Pharm Ther. 2011, 36: 33-44. 10.1111/j.1365-2710.2009.01151.x.CrossRefPubMed
16.
go back to reference Jano E, Aparasu RR: Healthcare outcomes associated with Beers' criteria: a systematic review. Ann Pharmacother. 2007, 41: 438-447. 10.1345/aph.1H473.CrossRefPubMed Jano E, Aparasu RR: Healthcare outcomes associated with Beers' criteria: a systematic review. Ann Pharmacother. 2007, 41: 438-447. 10.1345/aph.1H473.CrossRefPubMed
17.
go back to reference Borson S, Doane K: The impact of OBRA-87 on psychotropic drug prescribing in skilled nursing facilities. Psychiatr Serv. 1997, 48: 1289-1296.CrossRefPubMed Borson S, Doane K: The impact of OBRA-87 on psychotropic drug prescribing in skilled nursing facilities. Psychiatr Serv. 1997, 48: 1289-1296.CrossRefPubMed
18.
go back to reference Schneider LS, Dagerman KS, Insel P: Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005, 294: 1934-1943. 10.1001/jama.294.15.1934.CrossRefPubMed Schneider LS, Dagerman KS, Insel P: Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005, 294: 1934-1943. 10.1001/jama.294.15.1934.CrossRefPubMed
19.
go back to reference Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, Brookhart MA: Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005, 353: 2335-2341. 10.1056/NEJMoa052827.CrossRefPubMed Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, Brookhart MA: Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005, 353: 2335-2341. 10.1056/NEJMoa052827.CrossRefPubMed
20.
go back to reference Hartikainen S, Lönnroos E, Louhivuori K: Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci. 2007, 62: 1172-1181. 10.1093/gerona/62.10.1172.CrossRefPubMed Hartikainen S, Lönnroos E, Louhivuori K: Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci. 2007, 62: 1172-1181. 10.1093/gerona/62.10.1172.CrossRefPubMed
21.
go back to reference Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K: Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ. 2006, 332: 455-9. 10.1136/bmj.38740.439664.DE.CrossRefPubMedPubMedCentral Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K: Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ. 2006, 332: 455-9. 10.1136/bmj.38740.439664.DE.CrossRefPubMedPubMedCentral
22.
go back to reference Uusvaara J, Pitkala KH, Tienari PJ, Kautiainen H, Tilvis RS, Strandberg TE: Association between anticholinergic drugs and apolipoprotein e ε4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study. J Am Geriatr Soc. 2009, 57: 427-431. 10.1111/j.1532-5415.2008.02129.x.CrossRefPubMed Uusvaara J, Pitkala KH, Tienari PJ, Kautiainen H, Tilvis RS, Strandberg TE: Association between anticholinergic drugs and apolipoprotein e ε4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study. J Am Geriatr Soc. 2009, 57: 427-431. 10.1111/j.1532-5415.2008.02129.x.CrossRefPubMed
23.
go back to reference Uusvaara J, Pitkala KH, Kautiainen H, Tilvis RS, Strandberg TE: Association of anticholinergic drugs with hospitalization and mortality among older cardiovascular patients: a prospective study. Drugs Aging. 2011, 28: 131-138. 10.2165/11585060-000000000-00000.CrossRefPubMed Uusvaara J, Pitkala KH, Kautiainen H, Tilvis RS, Strandberg TE: Association of anticholinergic drugs with hospitalization and mortality among older cardiovascular patients: a prospective study. Drugs Aging. 2011, 28: 131-138. 10.2165/11585060-000000000-00000.CrossRefPubMed
24.
go back to reference Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE: The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008, 168: 508-513. 10.1001/archinternmed.2007.106.CrossRefPubMed Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE: The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008, 168: 508-513. 10.1001/archinternmed.2007.106.CrossRefPubMed
25.
go back to reference Bell S, Strandberg TE, Teramura-Gronblad M, Laurila JV, Tilvis RS, Pitkala KH: Use of proton-pump inhibitors and mortality among institutionalized older people. Arch Intern Med. 2010, 170: 1604-1605. 10.1001/archinternmed.2010.304.PubMed Bell S, Strandberg TE, Teramura-Gronblad M, Laurila JV, Tilvis RS, Pitkala KH: Use of proton-pump inhibitors and mortality among institutionalized older people. Arch Intern Med. 2010, 170: 1604-1605. 10.1001/archinternmed.2010.304.PubMed
26.
go back to reference Johnell K, Klarin I: The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf. 2007, 30: 911-918. 10.2165/00002018-200730100-00009.CrossRefPubMed Johnell K, Klarin I: The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf. 2007, 30: 911-918. 10.2165/00002018-200730100-00009.CrossRefPubMed
28.
go back to reference Forsetlund L, Eike MC, Gjerberg E, Vist GE: Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomised controlled trials. BMC Geriatr. 2011, 11: 16-10.1186/1471-2318-11-16.CrossRefPubMedPubMedCentral Forsetlund L, Eike MC, Gjerberg E, Vist GE: Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomised controlled trials. BMC Geriatr. 2011, 11: 16-10.1186/1471-2318-11-16.CrossRefPubMedPubMedCentral
29.
go back to reference Avorn J, Soumerai SB, Everitt DE, Ross-Degnan D, Beers MH, Sherman D, Salem-Schatz SR, Fields D: A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med. 1992, 327: 168-173. 10.1056/NEJM199207163270306.CrossRefPubMed Avorn J, Soumerai SB, Everitt DE, Ross-Degnan D, Beers MH, Sherman D, Salem-Schatz SR, Fields D: A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med. 1992, 327: 168-173. 10.1056/NEJM199207163270306.CrossRefPubMed
30.
go back to reference Meador KG, Taylor JA, Thapa PB, Fought RL, Ray WA: Predictors of antipsychotic withdrawal or dose reduction in a randomized controlled trial of provider education. J Am Geriatr Soc. 1997, 45: 207-210.CrossRefPubMed Meador KG, Taylor JA, Thapa PB, Fought RL, Ray WA: Predictors of antipsychotic withdrawal or dose reduction in a randomized controlled trial of provider education. J Am Geriatr Soc. 1997, 45: 207-210.CrossRefPubMed
31.
go back to reference Fossey J, Ballard C, Juszczak E, James I, Alder N, Jacoby R, Howard R: Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. BMJ. 2006, 332: 756-761. 10.1136/bmj.38782.575868.7C.CrossRefPubMedPubMedCentral Fossey J, Ballard C, Juszczak E, James I, Alder N, Jacoby R, Howard R: Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. BMJ. 2006, 332: 756-761. 10.1136/bmj.38782.575868.7C.CrossRefPubMedPubMedCentral
32.
go back to reference Crotty M, Halbert J, Rowett D, Giles L, Birks R, Williams H, Whitehead C: An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing. 2004, 33: 612-617. 10.1093/ageing/afh213.CrossRefPubMed Crotty M, Halbert J, Rowett D, Giles L, Birks R, Williams H, Whitehead C: An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing. 2004, 33: 612-617. 10.1093/ageing/afh213.CrossRefPubMed
33.
go back to reference Patterson SM, Hughes CM, Crealey G, Cardwell C, Lapane KL: An evaluation of an adapted U.S. model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland study). J Am Geriatr Soc. 2010, 58: 44-53. 10.1111/j.1532-5415.2009.02617.x.CrossRefPubMed Patterson SM, Hughes CM, Crealey G, Cardwell C, Lapane KL: An evaluation of an adapted U.S. model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland study). J Am Geriatr Soc. 2010, 58: 44-53. 10.1111/j.1532-5415.2009.02617.x.CrossRefPubMed
34.
go back to reference Roberts MS, Stokes JA, King MA, Lynne TA, Purdie DM, Glasziou PP, Wilson DA, McCarthy ST, Brooks GE, de Looze FJ, Del Mar CB: Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol. 2001, 51: 257-265.CrossRefPubMedPubMedCentral Roberts MS, Stokes JA, King MA, Lynne TA, Purdie DM, Glasziou PP, Wilson DA, McCarthy ST, Brooks GE, de Looze FJ, Del Mar CB: Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol. 2001, 51: 257-265.CrossRefPubMedPubMedCentral
35.
go back to reference Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA: Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother. 2004, 2: 257-264. 10.1016/j.amjopharm.2005.01.001.CrossRefPubMed Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA: Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother. 2004, 2: 257-264. 10.1016/j.amjopharm.2005.01.001.CrossRefPubMed
36.
go back to reference Folstein MF, Folstein SE, McHugh PR: "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975, 12: 189-198. 10.1016/0022-3956(75)90026-6.CrossRefPubMed Folstein MF, Folstein SE, McHugh PR: "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975, 12: 189-198. 10.1016/0022-3956(75)90026-6.CrossRefPubMed
37.
go back to reference Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry. 1982, 140: 566-572. 10.1192/bjp.140.6.566.CrossRefPubMed Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry. 1982, 140: 566-572. 10.1192/bjp.140.6.566.CrossRefPubMed
38.
go back to reference Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C: The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989, 39: 1159-1165. 10.1212/WNL.39.9.1159.CrossRefPubMed Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C: The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989, 39: 1159-1165. 10.1212/WNL.39.9.1159.CrossRefPubMed
39.
go back to reference Welsh K, Butters N, Hughes J, Mohs R, Heyman A: Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol. 1991, 48: 278-281. 10.1001/archneur.1991.00530150046016.CrossRefPubMed Welsh K, Butters N, Hughes J, Mohs R, Heyman A: Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol. 1991, 48: 278-281. 10.1001/archneur.1991.00530150046016.CrossRefPubMed
40.
go back to reference Sunderland T: Hill JL, Mellow AM, Lawlor BA, Gundersheimer J, Newhouse PA. Grafman JH: Clock drawing in Alzheimer's disease. A novel measure of dementia severity. J Am Geriatr Soc. 1989, 37: 725-729.PubMed Sunderland T: Hill JL, Mellow AM, Lawlor BA, Gundersheimer J, Newhouse PA. Grafman JH: Clock drawing in Alzheimer's disease. A novel measure of dementia severity. J Am Geriatr Soc. 1989, 37: 725-729.PubMed
41.
go back to reference Guigoz Y, Lauque S: Vellas BJ: Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. Clin Geriatr Med. 2002, 18: 737-757.CrossRefPubMed Guigoz Y, Lauque S: Vellas BJ: Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. Clin Geriatr Med. 2002, 18: 737-757.CrossRefPubMed
42.
go back to reference Routasalo PE, Tilvis RS, Kautiainen H, Pitkala KH: Effects of psychosocial group rehabilitation on social functioning, loneliness and well-being of lonely, older people: randomized controlled trial. J Adv Nurs. 2009, 65: 297-305. 10.1111/j.1365-2648.2008.04837.x.CrossRefPubMed Routasalo PE, Tilvis RS, Kautiainen H, Pitkala KH: Effects of psychosocial group rehabilitation on social functioning, loneliness and well-being of lonely, older people: randomized controlled trial. J Adv Nurs. 2009, 65: 297-305. 10.1111/j.1365-2648.2008.04837.x.CrossRefPubMed
43.
go back to reference Sintonen H: The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001, 33: 328-336. 10.3109/07853890109002086.CrossRefPubMed Sintonen H: The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001, 33: 328-336. 10.3109/07853890109002086.CrossRefPubMed
45.
go back to reference Morris JN, Fries BE, Bernabei R, Ikegami R, Carpenter I, Gilgen R, DuPasquier J, Frijters D, Henrard J, Hirdes JP, Belleville-Taylor P: RAI-home care (RAI-HC) assessment manual for version 2.0. 2000, Marblehead, MA: Opus Communications Morris JN, Fries BE, Bernabei R, Ikegami R, Carpenter I, Gilgen R, DuPasquier J, Frijters D, Henrard J, Hirdes JP, Belleville-Taylor P: RAI-home care (RAI-HC) assessment manual for version 2.0. 2000, Marblehead, MA: Opus Communications
46.
go back to reference Leikola S: Development and application of comprehensive medication review procedure to community-dwelling elderly. Dissertationes Biocentri Viikki Universitatis Helsingiensis. Helsinki University Printing House. 2012, 48: 65-Helsinki, Finland Leikola S: Development and application of comprehensive medication review procedure to community-dwelling elderly. Dissertationes Biocentri Viikki Universitatis Helsingiensis. Helsinki University Printing House. 2012, 48: 65-Helsinki, Finland
Metadata
Title
Reducing inappropriate, anticholinergic and psychotropic drugs among older residents in assisted living facilities: study protocol for a randomized controlled trial
Authors
Kaisu H Pitkala
Anna-Liisa Juola
Helena Soini
Marja-Liisa Laakkonen
Hannu Kautiainen
Mariko Teramura-Gronblad
Harriet Finne-Soveri
Mikko Bjorkman
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Trials / Issue 1/2012
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-13-85

Other articles of this Issue 1/2012

Trials 1/2012 Go to the issue